Breaking News: Cue Biopharma Sets Record with $12.0 Million Public Offering

Cue Biopharma Announces Public Offering of Common Stock September 26, 2024 Boston, MA Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company specializing in therapeutic biologics, has announced the pricing of an underwritten public offering of common stock. The offering includes 11,564,401 shares of common stock and accompanying common stock warrants, as well as pre-funded…

Read More

Get Ready to Invest: Theriva Biologics Drops the Mic with $2.5 Million Public Offering!

Theriva Biologics, Inc. Announces Pricing of Public Offering What’s the Buzz? Hey there, fellow financial enthusiasts! Have you heard the news about Theriva Biologics, Inc.’s recent announcement regarding its public offering? If not, let me fill you in on the deets. The diversified clinical-stage company is making waves in the biotech world with its development…

Read More

Unleashing the Geeky Goodness: Our Take on Dell & Super Micro Computer Stocks – The Long and Short of It

Welcome to the Dell AI Revolution Redefining the Tech Landscape It’s no secret that Dell has been dominating the AI server market, leaving its competitors in the dust. While other tech giants are scrambling to keep up, Dell has already solidified its position as a leader in this rapidly evolving field. The company’s relentless pursuit…

Read More

Breaking News: Banzai Closes $5M Private Placement Under Nasdaq Rules!

Banzai International, Inc. Announces Successful Closing of Private Placement SEATTLE, Sept. 26, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) Banzai International, Inc., a leading marketing technology company that offers essential solutions for marketing and sales, has recently completed a private placement offering at-the-market under the rules of the Nasdaq Stock Market. The company…

Read More